tetraiodothyroacetic acid has been researched along with Pancreatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bharali, DJ; Davis, FB; Davis, PJ; Lin, HY; Meng, R; Mousa, SA; Stain, SC; Sudha, T; Tang, HY; Yalcin, M | 1 |
| Bharali, DJ; Darwish, NH; Davis, PJ; Debreli Coskun, M; Keating, KA; Lin, HY; Mousa, SA; Sudha, T; Yalcin, M | 1 |
2 other study(ies) available for tetraiodothyroacetic acid and Pancreatic Neoplasms
| Article | Year |
|---|---|
Response of human pancreatic cancer cell xenografts to tetraiodothyroacetic acid nanoparticles.
Topics: Animals; bcl-X Protein; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Nanoparticles; Neovascularization, Pathologic; Pancreatic Neoplasms; Thyroxine; Transplantation, Heterologous | 2013 |
Targeted delivery of paclitaxel and doxorubicin to cancer xenografts via the nanoparticle of nano-diamino-tetrac.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Delivery Systems; Dynamic Light Scattering; Female; Humans; Lactic Acid; Mice, Nude; Nanoparticles; Paclitaxel; Pancreatic Neoplasms; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Thyroxine; Xenograft Model Antitumor Assays | 2017 |